SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

PCOS Rename? Critics Say PMOS Misses the Mark

While most experts agree that PCOS needed a new name, some participants at ENDO 2026 questioned both the new PMOS terminology and the process used to develop it.

When a Kid’s Bad Behavior Is Actually Hidden Sleep Disorder

In children, the effects of sleep problems may be even more pronounced than in adults because sleep is closely tied to growth, learning, and brain maturation.

Unapproved Retatrutide Use Challenges Clinicians

Non-FDA approved retatrutide is readily available to US consumers from multiple sources, leaving many clinicians grappling with how to manage patients taking the drug.

Imaging Predicts Therapy Failure in T2-T3 Glottic Cancers

Vertical anterior commissure involvement identified on preoperative imaging predicts poor outcomes in patients undergoing primary chemoradiotherapy for T2-T3 glottic tumours.

QOL After Weight-Loss Surgery Persists Despite Regain

In a prospective study, long-term improvements in QOL after metabolic and bariatric surgery are largely maintained in both patients experiencing weight regain of less than 30% and 30% or more.

Bariatric Surgery Outperforms Diet for Cancer Prevention

Metabolic/bariatric surgery is linked to a lower risk for multiple cancers in patients with severe obesity than dietary counseling, a large analysis shows.

Todays Updates

Younger Children With VTE: High Economic & Mortality Burden

Children and adolescents with venous thromboembolism, particularly children aged 4 years or younger, face a higher risk for mortality and economic burden.

Sugammadex Linked to Lower Respiratory Risks After Endoscopy

Block reversal using sugammadex is associated with better respiratory outcomes than that using neostigmine in adults undergoing upper gastrointestinal endoscopic procedures, a study finds.

Todays Updates

Younger Children With VTE: High Economic & Mortality Burden

Children and adolescents with venous thromboembolism, particularly children aged 4 years or younger, face a higher risk for mortality and economic burden.

Sugammadex Linked to Lower Respiratory Risks After Endoscopy

Block reversal using sugammadex is associated with better respiratory outcomes than that using neostigmine in adults undergoing upper gastrointestinal endoscopic procedures, a study finds.

Latest News

While most experts agree that PCOS needed a new name, some participants at ENDO 2026 questioned both the new PMOS terminology and the process used to develop it.

In children, the effects of sleep problems may be even more pronounced than in adults because sleep is closely tied to growth, learning, and brain maturation.

Non-FDA approved retatrutide is readily available to US consumers from multiple sources, leaving many clinicians grappling with how to manage patients taking the drug.

Vertical anterior commissure involvement identified on preoperative imaging predicts poor outcomes in patients undergoing primary chemoradiotherapy for T2-T3 glottic tumours.

In a prospective study, long-term improvements in QOL after metabolic and bariatric surgery are largely maintained in both patients experiencing weight regain of less than 30% and 30% or more.

Metabolic/bariatric surgery is linked to a lower risk for multiple cancers in patients with severe obesity than dietary counseling, a large analysis shows.

News All Time

Fasting and Calorie Restriction Work via Different Pathways

In adults with obesity, both intermittent fasting and calorie restriction lead to significant weight loss but act through distinct behavioral pathways.

GLP-1s Tied to Reduced Opioid Use in Chronic Pancreatitis

Among patients with chronic pancreatitis, GLP‑1 treatment is associated with a lower likelihood of initiating long-term opioid therapy or developing opioid use disorder.

NHS Recommends First Drug to Delay Type 1 Diabetes

NICE has recommended teplizumab — the first medicine to delay type 1 diabetes onset — in what Diabetes UK calls ‘a new age of treatment.’

GLP-1 Era Demands a New Model of Obesity Care

Panelists at HLTH Europe 2026 say obesity care must shift to lifelong digital models and shed its stigma as a moral failing.

Medicare to Cover New Osteoporosis Diagnostic Screening Test

Medicare coverage of a new osteoporosis screening tool may help to address the challenge of identifying and treating patients with osteoporosis by expanding access to screening.

Erosive Hand OA Flags Fracture Risk in Postmenopausal Women

Erosive hand osteoarthritis is associated with an increased risk for incident osteoporotic fractures in postmenopausal women, a study finds.

10-Hour Eating Window Boosts Weight Loss in Obesity

10-hour time-restricted eating promotes greater weight loss and improved body composition in adults with obesity and without diabetes than standard dietary counseling alone.

US Health Department Proposes Testosterone Therapy Label Updates

The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data ⁠and other...

The HPV Vaccine at 20: Progress Made, Challenges Ahead

Evidence supports HPV vaccination as a powerful cancer prevention tool, but improving its uptake remains critical for achieving long-term public health goals.

AGA Updates POWER Guide for Obesity, Weight Management

Updated guidance from the American Gastroenterological Association aims to help clinicians navigate the growing number of obesity and weight-management treatment options.

Breast Cancer Patients Taking GLP-1s Had Better Survival

The findings from a large observational study underscore the need for randomized clinical trials to assess the relationship between GLP-1 use and outcomes in patients with cancer.

MRI Predicts Survival Better Than Pathology in Rectal Cancer

MRI provides a more reliable preoperative prediction of survival and recurrence in patients with rectal tumour than traditional histopathology.

Early Use Of Novocure's Brain Cancer Therapy Shows no Significant Survival Benefit in Late-stage Trial

Novocure said on Thursday that a late-stage trial showed early use of its non-invasive cancer therapy ⁠did not significantly improve overall survival in patients with newly...

GLP-1s Could Help Improve Symptoms of PMOS

The metabolic symptoms of PMOS, including overweight and diabetes, may be effectively treated by GLP-1s.

Medicine Shortages Among Worst Ever Seen, Pharmacists Warn

Health leaders are calling for an emergency taskforce as record-breaking shortages hit patients and stretch pharmacies to the limit.

Tirzepatide Tops Semaglutide in Real-World Weight Loss

Tirzepatide leads to greater and faster weight loss than semaglutide in a real-world analysis of more than 20,000 patients with obesity.

Recommended News For You

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

Study suggests exercise could reduce breast cancer recurrence

Can certain food cravings predict a cancer diagnosis up to three months before other symptoms appear?

For the first time in humans, a chemotherapy drug reaches the brain.

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations

Glioblastoma treatment breakthrough shows promise

Recommended Articles For You

Advanced Directions in Oncology and Quality Improvement 

Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment 

Hematologic Toxicity of CDK4/6 Inhibitors in Breast Cancer: Meta-Analysis and Safety Data 

Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Accurately identified high-grade prostate cancer through urine testing.

2.

Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.

3.

Abemaciclib Slows Progression of Advanced Liposarcoma

4.

Detecting pancreatic cancer through changes in body composition and metabolism

5.

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

1.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

2.

Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine

3.

Decoding the Future: Cancer Genomics and Radiomics in Oncology

4.

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer

5.

Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

2.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

3.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

4.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

5.

Updates on Standard V/S High Risk Myeloma Treatment


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot